Does the Prostar XL vascular closure device compared to ProGlide affect major vascular complication rates in patients undergoing transfemoral TAVI?
ProGlide may be preferable to Prostar XL for vascular access site closure in transfemoral TAVI due to a lower rate of major vascular complications.
Prostar XL-based vascular closure in transfemoral TAVI procedures is associated with higher major vascular complication rates when compared with ProGlide; however, in-hospital mortality is similar with both devices.
Barbash et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: